NEW HAVEN, Connecticut medical device startup EpiEP Inc. has boosted its latest funding round to take in $1.4 million of a planned $1.5 million financing, according to SEC filings. The firm is a portfolio company of Connecticut Innovations.

EpiEP, Inc. has taken advantage of the knowledge and experience of global thought leaders in the field of cardiac arrhythmias to develop its initial product, the EpiAccess System. EpiAccess was developed as a novel access system for the minimally invasive treatment of certain cardiac conditions, or arrhythmias, in which there is abnormal electrical activity in the heart. Through EpiAccess, EpiEP will provide epicardial access to electrophysiologists for safer, more effective treatment of heart arrhythmias through clinical innovation and by partnering with global thought leaders.